EUVIMEDEUVIMED entdecken
Systematische ÜbersichtLeserbriefOpen Access

A systematic review of hair loss as a consequence of COVID ‐19 infection

Yasmine Abushukur iD, Meghan Mansour, Rafey Rehman iD, Ali Rida, Steven Daveluy iD

International Journal of Dermatology · 2023-08 · 62 (8)

DOI: 10.1111/ijd.16542 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Dermatology, online erschienen am 05.12.2022. Verfasst von Yasmine Abushukur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oakland University William Beaumont School of Medicine, Rochester, MI, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A systematic review of hair loss as a consequence of COVID-19 infection Dear Editor, In early 2020, the World Health Organization declared a pandemic following mass transmission of the COVID-19 virus. Numerous reports suggested a link between COVID-19 and hair loss. Our purpose was to comprehensively synthesize the different hair loss patterns, clinical characteristics, and patient demographics of individuals experiencing post-COVID-19 hair loss. Methods: The EMBASE and PubMed databases were searched for articles pertaining to “COVID-19” and “alopecia” or “hair loss.” A total of 208 results were screened, and 28 studies were included (Figure 1). The quality of evidence provided by the included studies was established in Table 1. A total of 1080 patients experienced one of four hair loss patterns: telogen effluvium (TE), alopecia areata (AA), anagen effluvium (AE), and fibrosing alopecia (FA). The majority (n = 1,036, 95.92%) presented with acute TE, while the remainder of patients presented with acute or worsening AA (n = 38, 3.52%), AE (n = 4, 0.37%), or FA (n = 2, 0.19%) following infection. Patients with AE, AA, TE, and FA experienced hair loss symptoms a mean of 10, 38, 56, and 90 days following infection, respectively. The three most common COVID-19 symptoms were dyspnea (n = 298/424, 70%), myalgia/arthralgia (n = 59/424, 14%), and anosmia/ageusia (n = 42/424, 10%). Of the studies that examined hospitalization status of TE patients, 90% of TE patients (n = 412/458) were hospitalized for COVID19 infection. Minoxidil, either oral (n = 23/258, 9%) or topical (n = 86/258, 33%), was the most commonly prescribed hair loss treatment. Resolution of hair loss was unreported in 922

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAlopecia

Autor:innen und Institutionen

  • Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
  • Department of Dermatology, Wayne State University, Dearborn, MI, USA.

ORCID-Profile: Yasmine Abushukur, Rafey Rehman, Steven Daveluy

Zitieren

APA

Abushukur, Y., Mansour, M., Rehman, R., Rida, A., & Daveluy, S. (2023). A systematic review of hair loss as a consequence of COVID ‐19 infection. International Journal of Dermatology, 62(8). https://doi.org/10.1111/ijd.16542

Vancouver

Abushukur Y, Mansour M, Rehman R, Rida A, Daveluy S. A systematic review of hair loss as a consequence of COVID ‐19 infection. International Journal of Dermatology. 2023;62(8). doi:10.1111/ijd.16542

BibTeX
@article{Abushukur2023,
  author = {Abushukur, Yasmine and Mansour, Meghan and Rehman, Rafey and Rida, Ali and Daveluy, Steven},
  title = {A systematic review of hair loss as a consequence of COVID ‐19 infection},
  journal = {International Journal of Dermatology},
  year = {2023},
  volume = {62},
  number = {8},
  doi = {10.1111/ijd.16542}
}
Kostenlos starten →